Description
The global DNA synthesis market was valued at USD 2.2 billion in 2025 and is projected to reach USD 6.3 billion by 2032, growing at a CAGR of 16.2% during the forecast period. DNA synthesis refers to the artificial production of customized DNA sequences using chemical or enzymatic synthesis technologies for research, diagnostic, therapeutic, and industrial applications. It enables scientists to design and manufacture precise genetic material without relying on naturally occurring DNA, making it a foundational technology for synthetic biology, molecular biology, genomics, gene editing, vaccine development, and precision medicine. The market encompasses oligonucleotide synthesis and gene synthesis services delivered through multiple synthesis technologies to support biotechnology companies, pharmaceutical manufacturers, academic institutions, contract research organizations, and clinical laboratories. As demand for engineered DNA continues to expand across life sciences, DNA synthesis has become a critical enabling technology for innovation in modern biotechnology.
Market growth is primarily driven by increasing investments in genomics research, rapid advancements in synthetic biology, expanding adoption of CRISPR and other gene-editing technologies, and rising development of cell and gene therapies. Growing utilization of synthetic DNA in molecular diagnostics, personalized medicine, biologics development, vaccine production, and precision therapeutics is further accelerating market expansion. Continuous technological advancements in high-throughput automation, enzymatic DNA synthesis, artificial intelligence-enabled sequence optimization, and scalable manufacturing platforms are improving synthesis accuracy, reducing turnaround time, and enhancing production efficiency. Strategic collaborations, manufacturing capacity expansion, and growing outsourcing of DNA synthesis services are strengthening industry competitiveness. Over the forecast period, the market is expected to benefit from expanding biotechnology research, increasing commercialization of advanced therapeutics, and continuous innovation across synthetic biology applications.
Key Highlights of the Report
• In terms of service, oligonucleotide synthesis dominates the global DNA synthesis market, driven by its extensive utilization in PCR, sequencing, molecular diagnostics, cloning, and gene-editing workflows.
• The gene synthesis segment is projected to record the fastest growth, supported by increasing demand for long and complex DNA constructs across synthetic biology, vaccine development, biologics research, and advanced therapeutic applications.
• Based on oligonucleotide synthesis, custom oligonucleotide synthesis continues to gain strong adoption as researchers increasingly require sequence-specific primers, probes, and customized nucleic acid products.
• By method, solid phase synthesis accounted for the dominant market position, supported by its established reliability, scalability, and widespread commercial adoption for DNA production.
• The PCR-based enzyme synthesis segment is anticipated to witness rapid growth owing to continuous technological improvements in enzymatic DNA synthesis and increasing demand for longer, highly accurate DNA sequences.
• Based on application, research and development dominates the market due to expanding investments in genomics, molecular biology, synthetic biology, and biotechnology research worldwide.
• The therapeutics segment is expected to emerge as the fastest-growing application, driven by increasing development of gene therapies, DNA therapeutics, cell therapies, and mRNA-based medicines.
• Based on end use, academic and research institutes hold the largest market share owing to continuous utilization of synthetic DNA across life science research, pathway engineering, and functional genomics studies.
• Contract research organizations (CROs) are projected to register the fastest growth as biotechnology and pharmaceutical companies increasingly outsource DNA synthesis activities to improve efficiency and reduce operational costs.
• North America dominates the global DNA synthesis market, supported by advanced biotechnology infrastructure, substantial R&D investments, strong pharmaceutical innovation, and the presence of leading market participants.
• Asia Pacific is projected to be the fastest-growing regional market, driven by expanding biotechnology industries, increasing research funding, growing genomic medicine initiatives, and rising healthcare investments across emerging economies.
• The competitive landscape remains moderately concentrated, with Thermo Fisher Scientific leading the global market through its comprehensive DNA synthesis portfolio, global manufacturing capabilities, and integrated genomics solutions.
• The top five companies maintain a significant share of the global market, supported by continuous investments in automation technologies, advanced synthesis platforms, and strategic partnerships that strengthen their competitive positioning.
• Rising demand for synthetic DNA in molecular diagnostics, infectious disease testing, precision medicine, and synthetic biology continues to create new commercial opportunities for market participants.
• Continuous innovation in enzymatic DNA synthesis, AI-assisted sequence optimization, high-throughput synthesis platforms, and scalable manufacturing technologies is expected to reshape the competitive landscape throughout the forecast period.
Key Company Profiles
• BIOMATIK
• Bioneer
• Eton Bioscience
• Eurofins Scientific
• GenScript Biotech
• IBA Lifesciences
• Kaneka Eurogentec
• OriGene Technologies
• ProteoGenix
• Shenzhen Shuxin Biotechnology
• Thermo Fisher Scientific
Data Source
Apelo Consulting employs comprehensive primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by Apelo Consulting dedicated team of qualified professionals with deep industry experience and expertise.
